3M Structural Reorganization Actions in Motion: Will It Boost Margins?

3M's restructuring efforts, including job cuts and the healthcare business spin-off, have started to improve profitability, with Q1 adjusted operating margin rising 220 bps to 23.5%. The company projects 2025 adjusted EPS of $7.60-$7.90 and organic revenue growth of 2-3%, while peers like Griffon Corp have also seen margin improvements, Honeywell's margins contracted due to rising costs. Despite the positive outlook, 3M's forward P/E ratio is above its industry average, and consensus earnings estimates for Q2 2025 and full-year 2025 have declined slightly.

Analysis

3M Company's ongoing structural reorganization, including significant job cuts and the 2024 spin-off of its healthcare unit, is yielding financial improvements. The company's total operating expenses fell 3.3% in the first quarter of 2025, following a 44% decline in 2024. In the first quarter, these restructuring actions, along with strong organic volume and productivity, increased 3M’s adjusted operating margin by 220 basis points year-over-year to 23.5%. For the full year 2025, 3M projects adjusted earnings per share between $7.60 and $7.90, up from $7.30 in 2024, and expects adjusted organic revenue growth of 2-3%, with adjusted operating margins anticipated to expand by 130-190 basis points. Comparatively, peer Griffon Corporation also improved its adjusted gross margin to 41.2% in its first quarter through cost management, while Honeywell International's first-quarter operating margin contracted 30 basis points to 20.1% due to higher expenses. Despite 3M's positive operational shifts and a 14.8% year-to-date stock appreciation (versus the industry's 0.6% growth), its valuation presents a mixed picture: the forward P/E ratio stands at 18.72X, exceeding the industry average of 16.87X and its five-year median of 15.98X, and it holds a Zacks Value Score of D. Reflecting some caution, the Zacks Consensus Estimate for 3M's earnings for second-quarter 2025 and for the full year 2025 have declined 1.5% and 1.8%, respectively, over the past 60 days, and the stock carries a Zacks Rank #3 (Hold).

Key Decisions for Investors

• Investors should weigh the demonstrated benefits of 3M's restructuring and its strong 2025 outlook against the stock's premium valuation, as indicated by its forward P/E ratio of 18.72X, and recent modest downward revisions in consensus earnings estimates.
• It is prudent to monitor the sustainability of margin expansion and the achievement of targeted 2-3% organic revenue growth for 2025 to validate the ongoing turnaround, particularly given the Zacks Rank #3 (Hold).
• Future investment decisions should consider upcoming earnings reports for further confirmation that operational improvements are translating into sustained financial outperformance relative to current market expectations and valuation.